Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

Kite Pharma Inc. (Nasdaq: KITE)

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. *

 

Period Start 2015-12-11 existent
  Group Gilead Sciences (Group)
Products Industry cancer immunotherapy (immuno-oncology, I-O)
  Industry 2 eACT™ (engineered autologous T cell therapy)
Person Person Belldegrun, Arie (Allogene 201806 Executive Chairman before Kite Pharma CEO)
     
  Street 2225 Colorado Avenue
  City 90404 Santa Monica, CA
  Tel +1-310-824-9999
    Address record changed: 2017-04-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Kite Pharma, Inc.. (12/11/15). "Press Release: Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares". Santa Monica, CA.
     
   
Record changed: 2018-09-12

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Gilead Sciences (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top